Literature DB >> 2391431

A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123.

A Emmendörffer1, M Hecht, M L Lohmann-Matthes, J Roesler.   

Abstract

Analysis of the functional activity of phagocytes is of great importance in the differential diagnosis of patients with recurrent bacterial infections. Here we describe a method to determine the production of reactive oxygen intermediates (ROI) by microcytofluorometry using dihydrorhodamine 123, a derivative of rhodamine 123. Using this method the ROI production of erythrocyte-depleted whole blood samples can be measured without further time-consuming purification steps. Possible harmful manipulation of the isolated cells can also be avoided and highly reproducible and significant results are obtained in the minimum of time. This assay provides a very sensitive alternative to the clinically used NBT test in the diagnosis of patients with chronic granulomatous disease (CGD). Moreover, the analysis of oxygen-dependent effector functions of murine effector cells and cell lines may be important in investigating resistance to certain microbes (e.g., Candida albicans, Staphylococcus aureus or different protozoa such as Toxoplasma gondii or Leishmania species).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391431     DOI: 10.1016/0022-1759(90)90198-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  51 in total

1.  Simulated microgravity impairs respiratory burst activity in human promyelocytic cells.

Authors:  J H Hughes; J P Long
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-04       Impact factor: 2.416

2.  Enhanced neutrophil response in chronic obstructive pulmonary disease.

Authors:  A Noguera; S Batle; C Miralles; J Iglesias; X Busquets; W MacNee; A G Agustí
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

3.  Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.

Authors:  D K Kaul; R P Hebbel
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

4.  Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice.

Authors:  Clarence David Williams; Mary Lynn Bajt; Anwar Farhood; Hartmut Jaeschke
Journal:  Liver Int       Date:  2010-10       Impact factor: 5.828

5.  Exploring post-translational arginine modification using chemically synthesized methylglyoxal hydroimidazolones.

Authors:  Tina Wang; Rendy Kartika; David A Spiegel
Journal:  J Am Chem Soc       Date:  2012-05-16       Impact factor: 15.419

6.  PRAM-1 is required for optimal integrin-dependent neutrophil function.

Authors:  Regina A Clemens; Sally A Newbrough; Elaine Y Chung; Shereen Gheith; Andrew L Singer; Gary A Koretzky; Erik J Peterson
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  Neutrophil responses to CRP are not dependent on polymorphism of human FcgammaRIIA (R131H).

Authors:  J A Rodríguez; K B Bodman-Smith; J G Raynes
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

8.  Assessing immune function in adult bronchiectasis.

Authors:  P T King; P Hutchinson; P W Holmes; N J Freezer; V Bennett-Wood; R Robins-Browne; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

9.  Enhanced lipid peroxidation by extracellular ATP in PC12 cells.

Authors:  Y Cheng; M Chen; M James-Kracke; P Wixom; A Y Sun
Journal:  Neurochem Res       Date:  1996-01       Impact factor: 3.996

10.  Microbially cleaved immunoglobulins are sensed by the innate immune receptor LILRA2.

Authors:  Kouyuki Hirayasu; Fumiji Saito; Tadahiro Suenaga; Kyoko Shida; Noriko Arase; Keita Oikawa; Toshifumi Yamaoka; Hiroyuki Murota; Hiroji Chibana; Ichiro Nakagawa; Tomoko Kubori; Hiroki Nagai; Yuji Nakamaru; Ichiro Katayama; Marco Colonna; Hisashi Arase
Journal:  Nat Microbiol       Date:  2016-04-25       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.